Results 191 to 200 of about 351,954 (346)

Adipokines as Prognostic Biomarkers in Multiple Myeloma: A Case-Control Study. [PDF]

open access: yesMedicina (Kaunas)
Obajed Al-Ali N   +10 more
europepmc   +1 more source

Posterior Encephalopathy Syndrome in a Patient with Multiple System Atrophy and Multiple Myeloma

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Jackson Mitzner   +3 more
wiley   +1 more source

The Cost of Love: Emotional Labour and Moral Tensions in the Lives of Chinese Young Carers

open access: yesThe British Journal of Sociology, EarlyView.
ABSTRACT Like adults, children also provide care. This article explores the emotional labour of young carers who care for ill or disabled family members in China, a context where children's caregiving remains largely invisible in both policy and scholarship.
Kefan Xue, Kaidong Guo
wiley   +1 more source

Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple Myeloma. [PDF]

open access: yesEJHaem
Ferri GM   +6 more
europepmc   +1 more source

Case Report of Maxillary Alveolar Rhabdomyosarcoma Misdiagnosed as Periapical Lesion: Clinicopathological Alerts and Life‐Saving Lessons for Dentists

open access: yesAustralian Endodontic Journal, EarlyView.
ABSTRACT This report describes a rare case of alveolar rhabdomyosarcoma initially presenting with clinical features resembling an endodontic lesion. A 15‐year‐old male presented with progressive right maxillary swelling initially treated as a dental abscess.
Saliha Akçay Köprücü   +3 more
wiley   +1 more source

High Implementation Adherence to Lenalidomide in Multiple Myeloma. [PDF]

open access: yesCancers (Basel)
Amitai I   +9 more
europepmc   +1 more source

Personalized Cancer Vaccines in the Clinical Trial Pipeline

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
This study analyzes the current landscape of personalized cancer vaccine clinical trials, highlighting trends in vaccine platforms, trial phases, and geographic distribution. Peptide and dendritic cell vaccines dominate early‐stage research, with promising immune responses observed in melanoma, glioblastoma, and urothelial cancer trials.
Liudmila Iamukova, Elena Alferova
wiley   +1 more source

Mapping VEXAS‐associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population

open access: yesBritish Journal of Haematology, EarlyView.
VEXAS syndrome is a late‐onset inflammatory disorder with rheumatological and haematological features. Epidemiological studies of VEXAS syndrome so far have been limited. Analysis of various UK cohorts estimates the incidence of VEXAS to be 1.51/100 000, or 171 new cases in the population of men over the age of 50 who are being investigated for myeloid
Ana Martinez Rodriguez   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy